Empirical third-generation cephalosporin therapy for adults with community-onset Enterobacteriaceae bacteraemia: Impact of revised CLSI breakpoints

International Journal of Antimicrobial Agents

Volumn 47, Issue 4, 2016, Pages 297-303

  Hsieh, Chih Chia ^a   Lee, Chung Hsun ^a   Li, Ming Chi ^a   Hong, Ming Yuan ^a   Chi, Chih Hsien ^a,b   Lee, Ching Chi ^a,b  

^a NATIONAL CHENG KUNG UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

Author keywords

Bacteraemia; Breakpoints; Clinical and Laboratory Standards Institute; Empirical therapy; Enterobacteriaceae; Third generation cephalosporins

Indexed keywords

CEFOTAXIME; CEFTRIAXONE; ANTIINFECTIVE AGENT;

ADULT; AGED; ARTICLE; BACTEREMIA; BROTH DILUTION; CITROBACTER; COMORBIDITY; ENTEROBACTER; ENTEROBACTERIACEAE INFECTION; ESCHERICHIA COLI; FEMALE; HUMAN; KLEBSIELLA OXYTOCA; KLEBSIELLA PNEUMONIAE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MINIMUM INHIBITORY CONCENTRATION; MORGANELLA MORGANII; MORTALITY; NONHUMAN; OBSERVATIONAL STUDY; PLESIOMONAS SHIGELLOIDES; PNEUMONIA; PRIORITY JOURNAL; PROTEUS MIRABILIS; RETROSPECTIVE STUDY; SERRATIA MARCESCENS; COMMUNITY-ACQUIRED INFECTIONS; ENTEROBACTERIACEAE INFECTIONS; MICROBIAL SENSITIVITY TEST; SURVIVAL ANALYSIS; TREATMENT OUTCOME; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BACTEREMIA; CEFOTAXIME; CEFTRIAXONE; COMMUNITY-ACQUIRED INFECTIONS; ENTEROBACTERIACEAE INFECTIONS; FEMALE; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 84961223732     PISSN: 09248579     EISSN: 18727913     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2016.01.010     Document Type: Article

References (26)

1. D.W. Bates, K.E. Pruess, and T.H. Lee How bad are bacteremia and sepsis? Outcomes in a cohort with suspected bacteremia Arch Intern Med 155 1995 593 598
2. D.C. Angus, W.T. Linde-Zwirble, J. Lidicker, G. Clermont, J. Carcillo, and M.R. Pinsky Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care Crit Care Med 29 2001 1303 1310
3. R.N. Brogden, A. Ward, and Ceftriaxone A reappraisal of its antibacterial activity and pharmacokinetic properties, and an update on its therapeutic use with particular reference to once-daily administration Drugs 35 1988 604 645
4. R.N. Jones, and C. Thornsberry Cefotaxime: a review of in vitro antimicrobial properties and spectrum of activity Rev Infect Dis 4 1982 S300 S315
5. Clinical and Laboratory Standards Institute Performance standards for antimicrobial susceptibility testing; twenty-fifth informational supplement. Document M100-S25 2015 CLSI Wayne, PA
6. Clinical Laboratory Standards Institute Performance standards for antimicrobial susceptibility testing; nineteenth informational supplement. Document M100-S19 2009 CLSI Wayne, PA
7. H.C. Chen, W.L. Lin, C.C. Lin, W.H. Hsieh, C.H. Hsieh, M.H. Wu, and et al. Outcome of inadequate empirical antibiotic therapy in emergency department patients with community-onset bloodstream infections J Antimicrob Chemother 68 2013 947 953
8. C.W. Chiu, M.C. Li, W.C. Ko, C.W. Li, P.L. Chen, C.M. Chang, and et al. Clinical impact of Gram-negative nonfermenters on adults with community-onset bacteremia in the emergency department J Microbiol Immunol Infect 48 2015 92 100
9. E. von Elm, D.G. Altman, M. Egger, S.J. Pocock, P.C. Gotzsche, J.P. Vandenbroucke, and et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies Lancet 370 2007 1453 1457
10. C.C. Lee, C.H. Lee, M.C. Chuang, M.Y. Hong, H.C. Hsu, and W.C. Ko Impact of inappropriate empirical antibiotic therapy on outcome of bacteremic adults visiting the ED Am J Emerg Med 30 2012 1447 1456
11. D.N. Gilbert, R.C. Moellering Jr., G.M. Eliopoulos, H.F. Chambers, and M.S. Saag Selected pharmacologic features of antimicrobial agents The Sanford guide to antimicrobial therapy 2014 Sanford Guide Sperryville, VA 92 111
12. H.S. Cheong, C.I. Kang, Y.M. Wi, E.S. Kim, J.S. Lee, K.S. Ko, and et al. Clinical significance and predictors of community-onset Pseudomonas aeruginosa bacteremia Am J Med 121 2008 709 714
13. D.L. Paterson, W.C. Ko, A. Von Gottberg, S. Mohapatra, J.M. Casellas, H. Goossens, and et al. International prospective study of Klebsiella pneumoniae bacteremia: implications of extended-spectrum β-lactamase production in nosocomial infections Ann Intern Med 140 2004 26 32
14. C. Brun-Buisson, F. Doyon, J. Carlet, P. Dellamonica, F. Gouin, A. Lepoutre, and et al. Incidence, risk factors, and outcome of severe sepsis and septic shock in adults. A multicenter prospective study in intensive care units. French ICU Group for Severe Sepsis JAMA 274 1995 968 974
15. R.P. Dellinger, M.M. Levy, J.M. Carlet, J. Bion, M.M. Parker, R. Jaeschke, and et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008 Intensive Care Med 34 2008 17 60
16. F.G. Schellevis, J. van der Velden, E. van de Lisdonk, J.T. van Eijk, and C. van Weel Comorbidity of chronic diseases in general practice J Clin Epidemiol 46 1993 469 473
17. U.I. Chang, H.W. Kim, and S.H. Wie Propensity-matched analysis to compare the therapeutic efficacies of cefuroxime versus cefotaxime as initial antimicrobial therapy for community-onset complicated nonobstructive acute pyelonephritis due to Enterobacteriaceae infection in women Antimicrob Agents Chemother 59 2015 2488 2495
18. D.L. Paterson Resistance in Gram-negative bacteria: Enterobacteriaceae Am J Med 119 2006 S20 S28
19. J. Rodríguez-Baño, E. Miró, M. Villar, A. Coelho, M. Gozalo, N. Borrell, and et al. Colonisation and infection due to Enterobacteriaceae producing plasmid-mediated AmpC β-lactamases J Infect 64 2012 176 183
20. European Committee on Antimicrobial Susceptibility Testing Breakpoint tables for interpretation of MICs and zone diameters. Version 5.0, 2015 2015 EUCAST http://www.eucast.org/fileadmin/src/media/PDFs/EUCAST-files/Breakpoint-tables/v-5.0-Breakpoint-Table-01.pdf [accessed 09.05.15]
21. A.J. Kallen, S.E. Beekmann, B. Limbago, A.L. Lentnek, P.M. Polgreen, J. Patel, and et al. Prevalence of β-lactam nonsusceptible Gram-negative bacilli and use and interpretation of current susceptibility breakpoints: a survey of infectious disease physicians Diagn Microbiol Infect Dis 71 2011 316 319
22. P.R. Hsueh, W.C. Ko, J.J. Wu, J.J. Lu, F.D. Wang, H.Y. Wu, and et al. Consensus statement on the adherence to Clinical and Laboratory Standards Institute (CLSI) antimicrobial susceptibility testing guidelines (CLSI-2010 and CLSI-2010-update) for Enterobacteriaceae in clinical microbiology laboratories in Taiwan J Microbiol Immunol Infect 43 2010 452 455
23. M.E. Falagas, G.S. Tansarli, P.I. Rafailidis, A. Kapaskelis, and K.Z. Vardakas Impact of antibiotic MIC on infection outcome in patients with susceptible Gram-negative bacteria: a systematic review and meta-analysis Antimicrob Agents Chemother 56 2012 4214 4222
24. C.I. Lee, N.Y. Lee, J.J. Yan, H.C. Lee, N.Y. Ko, C.M. Chang, and et al. Extended-spectrum β-lactamase-producing phenotype signifies a poor prognosis for patients with cefpodoxime-resistant Escherichia coli or Klebsiella pneumoniae bacteremia J Microbiol Immunol Infect 42 2009 303 309
25. C.C. Lee, N.Y. Lee, P.L. Chen, M.Y. Hong, T.Y. Chan, C.H. Chi, and et al. Impact of antimicrobial strategies on clinical outcomes of adults with septic shock and community-onset Enterobacteriaceae bacteremia: de-escalation is beneficial Diagn Microbiol Infect Dis 82 2015 158 164
26. P.D. Tamma, D.J. Sklansky, D.L. Palazzi, S.K. Swami, and A.M. Milstone Antibiotic susceptibility of common pediatric uropathogens in the United States Clin Infect Dis 59 2014 750 752